Whenever I search for potential penny stocks to buy, one small pharmaceutical firm keeps popping up. It’s Poolbeg Pharma (LSE: POLB), and it has a novel research model that’s light on cash, and offers the potential to develop multiple product lines at lower costs than traditional methods. There’s artificial ...
motleyfooluklse:mbhlse:kodlse:polb
Many investors look for penny shares that might offer very strong returns. In reality, there can be a lot of disappointments. But one penny share on the London market with a £70m capitalisation has already increased in value by 53% so far this year. Might it keep going – and should I buy some now? Strong ...
motleyfooluklse:polb
